Olivier Brandicourt has been appointed president and general manager of the Emerging Markets and Established Products Business Units at Pfizer. He succeeds David Simmons, who is leaving Pfizer to become the chairman and chief executive officer of PPD.   “Olivier is ideally suited to take on this new role,” said Ian Read, Pfizer chairman and chief executive officer. “He has more than 20 years of global experience in the pharmaceutical industry. Olivier is both a physician and proven business lead...